Hls Therapeutics Stock Analysis
| HLTRF Stock | USD 3.27 0.54 19.78% |
HLS Therapeutics is overvalued with Real Value of 3.05 and Hype Value of 3.27. The main objective of HLS Therapeutics pink sheet analysis is to determine its intrinsic value, which is an estimate of what HLS Therapeutics is worth, separate from its market price. There are two main types of HLS Therapeutics' stock analysis: fundamental analysis and technical analysis.
The HLS Therapeutics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and HLS Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
HLS |
HLS Pink Sheet Analysis Notes
About 64.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. HLS Therapeutics recorded a loss per share of 0.37. The entity last dividend was issued on the 30th of January 2023. HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. HLS Therapeutics Inc. was founded in 2018 and is headquartered in Etobicoke, Canada. Hls Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 92 people.The quote for HLS Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about HLS Therapeutics call Gilbert Godin at 647 495 9000 or check out https://www.hlstherapeutics.com.HLS Therapeutics Investment Alerts
| HLS Therapeutics had very high historical volatility over the last 90 days | |
| HLS Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 60.01 M. Net Loss for the year was (13.12 M) with profit before overhead, payroll, taxes, and interest of 50.36 M. | |
| About 64.0% of the company shares are owned by institutional investors |
HLS Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 231.54 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HLS Therapeutics's market, we take the total number of its shares issued and multiply it by HLS Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.HLS Profitablity
The company has Profit Margin (PM) of (0.35) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.19) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.19.Technical Drivers
As of the 24th of March, HLS Therapeutics retains the risk adjusted performance of 0.1014, and Market Risk Adjusted Performance of 0.9254. HLS Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out HLS Therapeutics variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if HLS Therapeutics is priced correctly, providing market reflects its last-minute price of 3.27 per share. Given that HLS Therapeutics has jensen alpha of 0.4443, we strongly advise you to confirm HLS Therapeutics's regular market performance to make sure the company can sustain itself at some point in the future.HLS Therapeutics Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. HLS Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for HLS Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
HLS Therapeutics Predictive Daily Indicators
HLS Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of HLS Therapeutics pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
HLS Therapeutics Forecast Models
HLS Therapeutics' time-series forecasting models are one of many HLS Therapeutics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary HLS Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About HLS Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how HLS Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling HLS shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as HLS Therapeutics. By using and applying HLS Pink Sheet analysis, traders can create a robust methodology for identifying HLS entry and exit points for their positions.
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. HLS Therapeutics Inc. was founded in 2018 and is headquartered in Etobicoke, Canada. Hls Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 92 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding HLS Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Complementary Tools for HLS Pink Sheet analysis
When running HLS Therapeutics' price analysis, check to measure HLS Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HLS Therapeutics is operating at the current time. Most of HLS Therapeutics' value examination focuses on studying past and present price action to predict the probability of HLS Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HLS Therapeutics' price. Additionally, you may evaluate how the addition of HLS Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |